Lipid levels in former gestational diabetic mothers

Diabetes Care

Volumn 19, Issue 12, 1996, Pages 1351-1356

  Meyers Seifer, Cynthia H ^a,b,c   Vohr, Betty R ^b  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MATERNAL DIABETES MELLITUS; RISK ASSESSMENT;

EID: 0029907072     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.12.1351     Document Type: Article

References (35)

1. O'Sullivan JB: Diabetes mellitus after GDM. Diabetes 40 (Suppl. 2):31-135, 1991
2. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic vascular disease. Diabetes Care 14:173-194, 1991
3. Zavoroni I, Dall'Aglio E, Alpi O, Bruschi F, Bonora E, Pezzarossa A, Butturini U: Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis 55:259-266, 1985
4. Ferrannini E, Bussigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S: Insulin resistance in essential hypertension. N Engl J Med 317:350-357, 1985
5. Kolterman OG, Insel J, Saikow M, Olefsky JM: Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest 65:1272-1284, 1980
6. Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferannini E, DeFronzo R: Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. J Clin Invest 84:205-213, 1989
7. Steiner G, Monta S, Vranic M: Resistance to insulin but not to glucagon in lean human hypertriglyceridemics. Diabetes 29:899-905, 1980
8. Catalano PM, Bernstein IM, Wolfe R, Srikanta S, Tyzbir E, Sims EAH: Subclinical abnormalities of glucose metabolism in subjects with previous gestational diabetes. Am J Obstet Gynecol 155:1255-1262, 1986.
9. Ward WK, Johnston CLW, Beard JC, Beneditti TJ, Halter JB, Pone D: Insulin resistance and impaired insulin secretion in subjects with a history of gestational diabetes mellitus. Diabetes 34:861-869, 1985
10. Efendic S, Hanson U, Persson BM, Wajngot, Luft R: Glucose tolerance, insulin release, and insulin sensitivity in normal-weight women with previous gestational diabetes mellitus. Diabetes 36:413-419, 1987
11. Kannel WB, Castelli WP, Gordon T, McNamara PM: Serum cholesterol, lipoproteins and risk of coronary heart disease: the Framingham Study. Ann Intern Med 74:1-12, 1971
12. Knopp RH, Magee MS, Larson MP, Beneditti T: Alternative tests and birth weight associations in pregnant women with abnormal glucose screening (Abstract). Diabetes 37 (Suppl. 1):110A, 1988
13. Hollingsworth DR, Grundy SM: Pregnancy-associated hypertriglyceridemia in normal and diabetic women: differences in insulin-dependent, non-insulin-dependent, and gestational diabetes. Diabetes 31:1092-1097, 1982
14. Skryten A, Johnson P, Samsioe G, Gustafson A: Studies in diabetic pregnancy. II. Serum lipids. Acta Obstet Gynecol Scand 55:211-217, 1976
15. Montelongo A, Lasuncion MA, Pallardo LF, Herrera E: Longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women. Diabetes 41:1651-1659, 1992
16. Kjos SL, Buchanina TA, Montor M, Coulson A, Mestman JH: Serum lipids within 36 months of delivery in women with recent gestational diabetes. Diabetes 40 (Suppl. 2):142-146, 1991
17. O'Sullivan JB, Mahan CM: Criteria for the oral glucose tolerance test in pregnancy. Diabetes 13:278-285, 1964
18. Carpenter MW, Coustan DR: Criteria for screening for gestational diabetes. Am J Obstet Gynecol 144:768-773, 1982
19. The Expert Panel: Report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 148:36-69, 1988
20. NIH Consensus Conference: Treatment of hypertriglyceridemia. JAMA 251:1196-1200, 1984
21. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease: Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 269:505-510, 1993
22. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
23. Kjos SL, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA: Predicting future diabetes in latino women with gestational diabetes: utility of early postpartum glucose tolerance testing. Diabetes 44:586-591, 1995
24. Coustan DR, Carpenter MW, O'Sullivan PS, Carr SR: Gestational diabetes: predictors of subsequent disordered glucose metabolism. Am J Obstet Gynecol 168:1139-1145, 1993
25. Catalano PM, Vargo KM, Bernstein IM, Amini SB: Incidence and risk factors associated with abnormal glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol 165:914-919, 1991
26. Bierman EL, Glomset JA: Disorders of lipid metabolism. In Williams Textbook of Endocrinology, 8th ed. Wilson JD, Foster DW Eds. Philadelphia, Saunders, 1992, p. 1366-1395
27. Howard BV: Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28:613-628, 1987
28. Wilson DE, Kwong LK, Elbein SC, Lalouel J-M: Genetic predispositon to hyperlipidemia in diabetes: the end of the beginning? J Intern Med 236 (Suppl. 736): 53-61, 1994
29. Wilson DE, Hata A, Kwong LK, Lingam A, Shuhua J, Ridinger D, Yeager C, Kaltenborn KC, Iverius P-H, Lalouel J-M: Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis and noninsulin-dependent diabetes. J Clin Invest 92:203-211, 1993
30. Shriver MD, Boerwinkle E, Hewett-Emmett D, Hanis CL: Frequency and effects of apolipoprotein E polymorphism in Mexican-American NIDDM subjects. Diabetes 40:334-337, 1991
31. Brown WV: Lipoprotein disorders in diabetes mellitus. Med Clin N A 78:143-161, 1994
32. Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassare H: Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency Proc Natl Acad Sci 91:9441-9445, 1994
33. Delyspere J-P: Modified lipoproteins in diabetes. J Intern Med 236:69-74, 1994
34. Austin, MA, Breslow JL Hennekens CH, Buring JE, Willett WC, Krauss RM: Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260:1917-1921, 1988
35. Haffner SM, Mykkanen L, Robbins D, Vladez R, Miettinen H, Howard BV, Stern MP, Bowsher R: A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects. Diabetologia 38:1328-1236, 1995